FORM 4 Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL OMB Number: 3235-0287 Expires: January 31, 2005 Estimated average burden hours per response... 0.5

(Print or Type Responses)

1. Name and Address of Reporting Person * Bacterial Robotics, LLC   2. Issuer Name and Ticker or Trading Symbol TAURIGA SCIENCES, INC. [TAUG] 5. Relationship of Reporting Person(s) to Issuer (Check all applicable) _____ Director __X__ 10% Owner _____ Officer (give title below) _____ Other (specify below) (Last) (First) (Middle) PO BOX 30085 3. Date of Earliest Transaction (Month/Day/Year) 07/08/2014 (Street) CINCINNATI, OH 45230 4. If Amendment, Date Original Filed(Month/Day/Year) 6. Individual or Joint/Group Filing(Check Applicable Line) _X_ Form filed by One Reporting Person ___ Form filed by More than One Reporting Person (City) (State) (Zip) Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned

1.Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4) Code V Amount (A) or (D) Price Common Stock               3,501,000 (1) D   Common Stock 07/08/2014   M   75,000,000 A $ 0.026 75,060,000 (2) D   Common Stock 07/08/2014   F   59,414,991 (3) D $ 0.0328 15,645,009 (2) D

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
	Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.		SEC 1474 (9-02)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)

1. Title of Derivative Security (Instr. 3)

2. Conversion or Exercise Price of Derivative Security

3. Transaction Date (Month/Day/Year)

3A. Deemed Execution Date, if any (Month/Day/Year)

4. Transaction Code (Instr. 8)

5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4, and 5)

6. Date Exercisable and Expiration Date (Month/Day/Year)

7. Title and Amount of Underlying Securities (Instr. 3 and 4)

8. Price of Derivative Security (Instr. 5)

9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)

10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4)

11. Nature of Indirect Beneficial Ownership (Instr. 4)

Code

V

(A)

(D)

Date Exercisable

Expiration Date

Title

Amount or Number of Shares

Common Stock Warrants (Right to Buy)

$ 0.026

07/08/2014

M

75,000,000 (4)

10/29/2013

10/29/2018

Common Stock

75,000,000

$ 0

0

D

Reporting Owners

Reporting Owner Name / Address	Relationships
	Director	10% Owner	Officer	Other
Bacterial Robotics, LLC PO BOX 30085 CINCINNATI, OH 45230		X

Signatures

/s/ Jason E. Barkeloo, Chief Executive Officer of Bacterial Robotics, LLC		07/09/2014
**Signature of Reporting Person		Date

Explanation of Responses:

*	If the form is filed by more than one reporting person, see Instruction 4(b)(v).
**	Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
(1)	The shares of common stock are owned directly by Jason E. Barkeloo ("Mr. Barkeloo"), a reporting person hereunder.
(2)	The shares of common stock are owned directly by Bacterial Robotics, LLC ("Bacterial Robotics"). As managing member and Chief Executive Officer of Bacterial Robotics and by virtue of the Voting Agreement, dated January 28, 2014, by and among the Company and members of Pilus Energy (the "Voting Agreement"), as disclosed in the reporting persons' Schedule 13D filed with the Securities and Exchange Commission on May 2, 2014, Mr. Barkeloo may be deemed to beneficially own the shares of common stock held by Bacterial Robotics.
(3)	Shares delivered in connection with the cashless exercise of 75,000,000 warrants, previously granted pursuant to the Strategic Alliance Agreement, dated as of October 29, 2013, by and between the Tauriga Sciences, Inc. and Bacterial Robotics (the "Strategic Alliance Agreement"), at an exercise price of $0.0260, as reported herein.
(4)	The warrant was issued pursuant to the Strategic Alliance Agreement and is owned directly by Bacterial Robotics. As managing member and Chief Executive Officer of Bacterial Robotics and by virtue of the Voting Agreement, Mr. Barkeloo may be deemed to beneficially own the securities held by Bacterial Robotics.

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB number.